230 related articles for article (PubMed ID: 12231530)
21. Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors.
Kurtz A; Lueth M; Kluwe L; Zhang T; Foster R; Mautner VF; Hartmann M; Tan DJ; Martuza RL; Friedrich RE; Driever PH; Wong LJ
Mol Cancer Res; 2004 Aug; 2(8):433-41. PubMed ID: 15328370
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial DNA mutations in chemical carcinogen-induced rat bladder and human bladder cancer.
Chen GF; Chan FL; Hong BF; Chan LW; Chan PS
Oncol Rep; 2004 Aug; 12(2):463-72. PubMed ID: 15254717
[TBL] [Abstract][Full Text] [Related]
23. Number of somatic mutations in the mitochondrial D-loop region indicates poor prognosis in breast cancer, independent of TP53 mutation.
Kuo SJ; Chen M; Ma GC; Chen ST; Chang SP; Lin WY; Chen YC; Lee TH; Lin TT; Liu CS
Cancer Genet Cytogenet; 2010 Sep; 201(2):94-101. PubMed ID: 20682393
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer.
Tan DJ; Bai RK; Wong LJ
Cancer Res; 2002 Feb; 62(4):972-6. PubMed ID: 11861366
[TBL] [Abstract][Full Text] [Related]
25. Identification of cystatin B as a potential serum marker in hepatocellular carcinoma.
Lee MJ; Yu GR; Park SH; Cho BH; Ahn JS; Park HJ; Song EY; Kim DG
Clin Cancer Res; 2008 Feb; 14(4):1080-9. PubMed ID: 18281540
[TBL] [Abstract][Full Text] [Related]
26. Differences in molecular alterations of hepatocellular carcinoma between patients with a sustained virological response and those with hepatitis C virus infection.
Hayashi T; Tamori A; Nishikawa M; Morikawa H; Enomoto M; Sakaguchi H; Habu D; Kawada N; Kubo S; Nishiguchi S; Shiomi S
Liver Int; 2009 Jan; 29(1):126-32. PubMed ID: 18492017
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial DNA mutations and 8-hydroxy-2'-deoxyguanosine Content in Japanese patients with urinary bladder and renal cancers.
Wada T; Tanji N; Ozawa A; Wang J; Shimamoto K; Sakayama K; Yokoyama M
Anticancer Res; 2006; 26(5A):3403-8. PubMed ID: 17094459
[TBL] [Abstract][Full Text] [Related]
28. Single nucleotide polymorphism in the promoter region of human alpha-fetoprotein (AFP) gene and its significance in hepatocellular carcinoma (HCC).
Chen GG; Ho RL; Wong J; Lee KF; Lai PB
Eur J Surg Oncol; 2007 Sep; 33(7):882-6. PubMed ID: 17433605
[TBL] [Abstract][Full Text] [Related]
29. High frequency of mitochondrial DNA D-loop mutations in Ewing's sarcoma.
Yu M; Wan Y; Zou Q; Xi Y
Biochem Biophys Res Commun; 2009 Dec; 390(3):447-50. PubMed ID: 19785995
[TBL] [Abstract][Full Text] [Related]
30. Specific p53 mutations detected in plasma and tumors of hepatocellular carcinoma patients by electrospray ionization mass spectrometry.
Jackson PE; Qian GS; Friesen MD; Zhu YR; Lu P; Wang JB; Wu Y; Kensler TW; Vogelstein B; Groopman JD
Cancer Res; 2001 Jan; 61(1):33-5. PubMed ID: 11196182
[TBL] [Abstract][Full Text] [Related]
31. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
32. Mutations of mitochondrial DNA as potential biomarkers in breast cancer.
Cai FF; Kohler C; Zhang B; Chen WJ; Barekati Z; Garritsen HS; Lenner P; Toniolo P; Zhang JJ; Zhong XY
Anticancer Res; 2011 Dec; 31(12):4267-71. PubMed ID: 22199290
[TBL] [Abstract][Full Text] [Related]
33. Tandem duplication/triplication correlated with poly-cytosine stretch variation in human mitochondrial DNA D-loop region.
Hung WY; Lin JC; Lee LM; Wu CW; Tseng LM; Yin PH; Chi CW; Lee HC
Mutagenesis; 2008 Mar; 23(2):137-42. PubMed ID: 18252697
[TBL] [Abstract][Full Text] [Related]
34. Somatic mitochondrial mutations in melanoma resection specimens.
Deichmann M; Kahle B; Benner A; Thome M; Helmke B; Näher H
Int J Oncol; 2004 Jan; 24(1):137-41. PubMed ID: 14654950
[TBL] [Abstract][Full Text] [Related]
35. Detection of mitochondrial DNA alterations in primary tumors and corresponding serum of colorectal cancer patients.
Hibi K; Nakayama H; Yamazaki T; Takase T; Taguchi M; Kasai Y; Ito K; Akiyama S; Nakao A
Int J Cancer; 2001 Nov; 94(3):429-31. PubMed ID: 11745425
[TBL] [Abstract][Full Text] [Related]
36. Ser-249 TP53 and CTNNB1 mutations in circulating free DNA of Egyptian patients with hepatocellular carcinoma versus chronic liver diseases.
Hosny G; Farahat N; Tayel H; Hainaut P
Cancer Lett; 2008 Jun; 264(2):201-8. PubMed ID: 18313840
[TBL] [Abstract][Full Text] [Related]
37. Mutations in the D-loop region and increased copy number of mitochondrial DNA in human laryngeal squamous cell carcinoma.
Guo W; Yang D; Xu H; Zhang Y; Huang J; Yang Z; Chen X; Huang Z
Mol Biol Rep; 2013 Jan; 40(1):13-20. PubMed ID: 23114912
[TBL] [Abstract][Full Text] [Related]
38. Detection of mitochondrial DNA mutations in gestational trophoblastic disease.
Chiu PM; Liu VW; Ngan HY; Khoo US; Cheung AN
Hum Mutat; 2003 Aug; 22(2):177. PubMed ID: 12872261
[TBL] [Abstract][Full Text] [Related]
39. Control region mutations and the 'common deletion' are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma.
Abnet CC; Huppi K; Carrera A; Armistead D; McKenney K; Hu N; Tang ZZ; Taylor PR; Dawsey SM
BMC Cancer; 2004 Jul; 4():30. PubMed ID: 15230979
[TBL] [Abstract][Full Text] [Related]
40. Detection of mitochondrial DNA mutations in pancreatic cancer offers a "mass"-ive advantage over detection of nuclear DNA mutations.
Jones JB; Song JJ; Hempen PM; Parmigiani G; Hruban RH; Kern SE
Cancer Res; 2001 Feb; 61(4):1299-304. PubMed ID: 11245424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
